Dr. Fábio Morato de Oliveira is a Brazilian researcher and Associate Professor of Human and Medical Genetics at the Federal University of Jataí (UFJ). His academic and research interests focus on molecular genetics, cytogenomics, and genomic instability in human diseases, particularly cancer and hematological malignancies. His work integrates classical and molecular cytogenetic approaches—including fluorescence in situ hybridization (FISH), comparative genomic hybridization, and advanced genomic analyses—to investigate chromosomal alterations, telomere biology, and gene expression in tumor cells and stem cells. A central theme of his research is the study of the three-dimensional organization of telomeres and its relationship with genomic instability, tumor progression, and therapeutic response. His studies also explore the role of mitotic regulators, such as the Aurora kinase genes AURKA and AURKB, as potential biomarkers and therapeutic targets. In addition, Dr. Oliveira is engaged in translational and population genomics initiatives in Brazil, including projects aimed at integrating genomic data into public health strategies and precision medicine.
Dr. Fábio Morato de Oliveira is a Brazilian researcher and Associate Professor of Human and Medical Genetics at the Federal University of Jataí (UFJ). His academic and research interests focus on molecular genetics, cytogenomics, and genomic instability in human diseases, particularly cancer and hematological malignancies. His work integrates classical and molecular cytogenetic approaches—including fluorescence in situ hybridization (FISH), comparative genomic hybridization, and advanced genomic analyses—to investigate chromosomal alterations, telomere biology, and gene expression in tumor cells and stem cells. A central theme of his research is the study of the three-dimensional organization of telomeres and its relationship with genomic instability, tumor progression, and therapeutic response. His studies also explore the role of mitotic regulators, such as the Aurora kinase genes AURKA and AURKB, as potential biomarkers and therapeutic targets. In addition, Dr. Oliveira is engaged in translational and population genomics initiatives in Brazil, including projects aimed at integrating genomic data into public health strategies and precision medicine.